GSK, Pfizer RSV shots must warn about rare paralysis risk
Barré for every million doses given.
Hosted on MSN10h
FDA Adds Guillain-Barre Syndrome Warning to Two RSV Vaccines
Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...
healthday5h
Eight in 10 Infants Received RSV Protection in the 2023 to 2024 Season
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according ...
FiercePharma12h
RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
BioSpace15h
GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome Warnings
A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...
Flu, COVID-19, RSV: Oneida County Health Department warns of respiratory illnesses
“As of December 28, Oneida County has had 386 flu cases reported since the flu season began,” said Daniel W. Gilmore, Ph.D., ...
RSV emergency department visits remain high in Florida. What to know
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
Monthly Prescribing Reference11h
RSV Vaccine Labeling Updated With Guillain-Barré Syndrome Warning
Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.
Medscape1d
RSV Vaccines and Treatments Face Global Access Hurdles
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
RSV activity is 'increasing' in Wisconsin, DHS says. Here's what you should know
For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease ...